We are live on ! Find out more
ALIM

Alimera Sciences

Delisted

ALIM was delisted on the 13th of September, 2024.

19 hedge funds and large institutions have $7.99M invested in Alimera Sciences in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

34% more capital invested

Capital invested by funds: $5.95M → $7.99M (+$2.03M)

5% less funds holding

Funds holding: 2019 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
19
Holders Change
-1
Holders Change %
-5%
% of All Funds
0.34%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
3
Increased
6
Reduced
Closed
4
Calls
Puts
Net Calls
Net Calls Change

ALIM Hedge Fund Activity: Q4 2020 in Review

19 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q4 2020, worth a combined $7.99M — up 34% from $5.95M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of ALIM and 3 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 6 added.

The largest buyer was Morgan Stanley, adding an estimated $1.86M. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $2.02M sold.

  • 19 institutional investors held Alimera Sciences (ALIM) as of Q4 2020, down from 20 in Q3 2020.
  • Funds reported $7.99M of Alimera Sciences stock for Q4 2020, up 34% quarter-over-quarter.
  • 3 funds opened new Alimera Sciences positions in Q4 2020 and 4 closed out, a net change of -1 holder.
  • The largest Alimera Sciences buyer in Q4 2020 was Morgan Stanley, an estimated $1.86M added.
  • The largest Alimera Sciences seller in Q4 2020 was Avoro Capital Advisors, an estimated $2.02M sold.

Based on aggregated 13F filings for Q4 2020.